NEW YORK (GenomeWeb) – OpGen announced today that it has priced a previously announced $10 million public offering of 25 million units of common stock and common warrants at $.40 per unit.
Registering provides access to this and other free content.
Already have an account?Login Now.
NPR reports that Turkish high school students will no longer study evolution.
Researchers report they sequenced and identified plant species in an "al fresco" laboratory.
An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.
In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.